Lý Quốc Trung, MD, PhD

Dr. Quốc Trung tham gia IBSG với vai trò Cố Vấn Học Thuật từ năm 2017. Hiện tại, Dr. Quốc Trung đang công tác tại Bệnh Viện Đa Khoa Sóc Trăng.

Education:

Kanazawa University, Japan: Postdoc researcher, Cellular Transplantation Biology (3/2014 – 7/2014).

Kanazawa University Graduate School of Medical Science, Ishikawa, Japan: PhD,  Cellular Transplantation Biology (2011 – 2014).

University of Medicine and Pharmacy at Ho Chi Minh City: Master of Science in Medicine (2005 – 2007).

University of Medicine and Pharmacy at Ho Chi Minh City: Medical Doctor (1994 – 2000).

Employment:

Soctrang General Hospital: Assistant Head, General Planning Department (2014 – Present).

Soctrang General Hospital: Attending Physician, then Assistant Head (2000 – 2011).

Achievements:

Completed PhD course in 3 years (one year sooner)

Reporter at the 55th ASH (American Association of Hematology) Annual Meeting. New Orleans, USA, December, 2013. RESVERATROL

Resveratrol inhibits myeloid leukemia cell lines with JAK2V617F via both inactivation of the JAK/STAT pathway and upregulation of the ERK pathway.

Reporter at the 54th ASH (American Association of Hematology) Annual Meeting. Atlanta, USA, December, 2012.

Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibition.

Reporter at the 74th Annual Meeting of the Japanese Society of Hematology, Kyoto, October, 2012.

Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibition.

Usui International Medical Scholarship for international student at Kanazawa University (2011 – 2014).

Scholardship from Mekong1000 Project of the Government of Vietnam for Ph.D course at Kanazawa University (2011 – 2014).

Publication:

1. Trung, Ly Quoc, Mostafa Ebraheem Morra, Nguyen Duc Truong, Tarek Turk, Ahmed Elshafie, Amr Foly, Dao Ngoc Hien Tam, Ahmed Iraqi, Trinh Thi Hong Van, Ahmed Elgebaly, Tran Nhu Ngoc, Tran Le-Huy Vu, Kenji Hirayam, Juntra Karbwang, and Nguyen Tien Huy*. A systematic review finds underreporting of ethics approval, informed consent, and incentives in clinical trials. Journal of Clinical Epidemiology. Volume 91. Page 80-86. November 2017. IF = 4.978.

2. “Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia”, An T. T. Dao, Hirohito Yamazaki, Hiroyuki Takamatsu, Chiharu Sugimori, Takamasa Katagiri,Hiroyuki Maruyama, Yoshitaka Zaimoku, Kana Maruyama, Trung Q. Ly, Luis Espinoza, Shinji Nakao, Annals of Hematology, 2016. IF = 3.083Citation = 7.

3. “Stilbene derivatives from melinjo extract have antioxidant and immune modulatory effects in healthy individuals”, JL Espinoza, DT An, LQ Trung, K Yamada, S Nakao, A Takami, Integrative Molecular Medicine, 2015. Citation = 4.

4. “Resveratrol selectively induces apoptosis in malignant cells with the JAK2V617F mutation by inhibiting the JAK2 pathway”, Ly Quoc Trung, J Luis Espinoza, Dao T An, Nguyen Hoang Viet, Kazuya Shimoda, Shinji Nakao, Molecular nutrition & food research, 2015. IF = 4.323. Citation = 10.

5. “Paraptosis Cell Death Induction by the Thiamine Analog Benfotiamine in Leukemia Cells”, Naomi Sugimori, J Luis Espinoza, Ly Quoc Trung, AkiyoshiTakami, Yukio Kondo, Dao Thi An, Motoko Sasaki, Tomohiko Wakayama, Shinji Nakao, PlosOne, 2015. (co-first author). IF = 2.806. Citation = 13.

6. “Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibition”, Ly Q Trung, Luis J Espinoza, Dao TT An, Shinji Nakao, PlosOne, 2013. IF = 2.806. Citation = 62.

7. “Ataxia-telangiectasia mutated kinase-mediated upregulation of NKG2D ligands on leukemia cells by resveratrol results in enhanced natural killer cell susceptibility”, J Luis Espinoza, AkiyoshiTakami, Ly Q Trung, Shinji Nakao,Cancer Science, 2013. IF = 3.974. Citation = 17.

8. “Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cells”, J Luis Espinoza, AkiyoshiTakami, Ly Quoc Trung, Shunichi Kato, Shinji Nakao,PlosOne, 2012. IF = 2.086. Citation = 37.

9. “Clinical Aspects and Treatment of Dengue Shock Syndrome in Children at Soc Trang General Hospital”, Ly Quoc Trung, Nguyen Thanh Hung, Lam Thi My, Journal of Medicine of Ho Chi Minh City, 2007.

Ý Kiến Độc Giả: